Journal article

Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer

Stephanie Berger, Erik Procko, Daciana Margineantu, Erinna F Lee, Betty W Shen, Alex Zelter, Daniel-Adriano Silva, Kusum Chawla, Marco J Herold, Jean-Marc Gamier, Richard Johnson, Michael J MacCoss, Guillaume Lessene, Trisha N Davis, Patrick S Stayton, Barry L Stoddard, W Douglas Fairlie, David M Hockenbery, David Baker



Awarded by National Institutes of Health

Awarded by Defense Threat Reduction Agency

Awarded by Howard Hughes Medical Institute

Awarded by Worldwide Cancer Research

Awarded by Cancer Council Victoria

Awarded by National Health and Medical Research Council

Awarded by Australian Research Council

Funding Acknowledgements

National Institutes of Health P41GM103533 Stephanie Berger Erik Procko David BakerDefense Threat Reduction Agency HDTRA1-10-0040 Stephanie Berger Erik Procko David BakerHoward Hughes Medical Institute HHMI-027779 Stephanie Berger Erik Procko David BakerNational Science Foundation Graduate Research Fellowship Program Stephanie BergerWorldwide Cancer Research 15-0025 Erinna F Lee W Douglas FairlieCancer Council Victoria 1057949 Erinna F Lee W Douglas FairliePew Charitable Trusts Daniel-Adriano SilvaConsejo Nacional de Ciencia y Tecnologia Daniel-Adriano SilvaNational Health and Medical Research Council 1024620 Erinna F LeeAustralian Research Council FT150100212 Erinna F LeeNational Institutes of Health R01 GM115545 Betty W Shen Barry L StoddardNational Institutes of Health R01 CA158921-04 Daciana Margineantu David M HockenberyVictorian Government, Australia Operational Infrastructure Support Program Erinna F Lee W Douglas FairlieThe funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.